Activity and research directory projects
The directory lists antimicrobial resistance (AMR) activities and research and displays whether they are in progress or completed. Use the filters and search to help refine your query.27 activities or research projects found
- 27 June 2019We are working with clinicians in the Center for Innovative Phage Applications and Therapeutics at the University of California in San Diego. Phage therapy is frontier medicine, and has FDA approval for use in hospitals in the USA. Isolating clinically-effective "cocktails" is a challenge that can only be met by collaboration between research scientists trained in phage biology (Monash) and clinicians with experience in clinical deployment (UCSD).Monash University.
University of California in San Diego.
- 27 June 2019We have engaged with partners in Wenzhou, China to analyze the recent rise in AMR in their hospitals. In 2019, we opened the Monash BDI-WMU Alliance in Clinical and Experimental Biomedicine on the campus of Wenzhou Medical University. Initial assessments of one species of bacteria reveals that 15 years ago, less than ten patients per annum were infected, all of which responded to off the shelf antibiotics. Last year, 990 patients had infections s, with ~1 in 3 being AMR.Biomedicine Discovery Institute, Monash University, Australia.
Wenzhou Medical University, China.
- 1 September 2018Antimicrobial Resistance: Science, Communication and Public Engagements (AMR-scapes) is funded by an Australian Research Council Discovery Project grant (DP170100937) to research public engagements with advice regarding the rational and reduced use of antibiotics. The project is led by Mark Davis, Andrea Whittaker, Mia Lindgren (Monash University), Monika Djerf-Pierre (University of Gothenburg and Monash University), and Paul Flowers (Glasgow Caledonian University).Monash University
- 7 August 2018This PhD research project is aimed at investigating alternative regulatory and funding models for antimicrobial drugs. The current economic model (where sales volumes and price determine the return on investment for a drug) does not foster appropriate antimicrobial use. Financial risks associated with AMR has resulted in a decline in the marketing of new drugs & insecurity of supply of current antimicrobials. This project is focused on the Australian market within a global context.University of Adelaide
- 5 July 2018This project is an initiative of WARRA, the Wollongong Antimicrobial Resistance Research Alliance. This project aims to develop and investigate the psychometric properties of a questionnaire measuring factors contributing to antibiotic use within the community, utilising the Theory of Planned Behaviour as a means of predicting problematic behaviour with antibiotics and informing future intervention strategies.University of Wollongong
- 5 July 2018WARRA, the Wollongong Antimicrobial Resistance Research Alliance, has developed a workshop series initiative with the aim of engaging pharmacists in the Illawarra Shoalhaven region. The workshop series will provide a continuing professional development (CPD) accredited platform for pharmacists to engage with researchers regarding antibiotic use and antimicrobial resistance.University of Wollongong
- 5 July 2018This project is an initiative of WARRA, the Wollongong Antimicrobial Resistance Research Alliance. This project aims to identify the trends in antimicrobial resistance over a 10 year period across the Illawarra Shoalhaven region for organisms including staphylococcus aureus, escherichia coli, klebsiella pneumonia, enterobacter spp, pneumococcus and haemophilus influenza. It further aims to determine the evolution of antimicrobial resistance in an individual over time.University of Wollongong, Illawarra Shoalhaven Local Health District, NSW Health Pathology, Southern IML
- 5 July 2018This project is an initiative of WARRA, the Wollongong Antimicrobial Resistance Research Alliance. The project aims to examine the relationship between antimicrobial resistance and patient health care service utilisation rates and clinical outcomes across the Illawarra Shoalhaven region. It is hypothesized that antimicrobial resistance is associated with higher utilization of health care resources and with poorer outcomes.University of Wollongong, Illawarra Shoalhaven Local Health District, in collaboration with Centre for Health Research Illawarra Shoalhaven Population
- 5 July 2018With regional, rural and metropolitan areas and a well-defined coastal strip with a relatively stable population base, the Illawarra Shoalhaven region provides an ideal population to position itself as the ‘Framingham’ of antimicrobial resistance. This large scale project specifically aims to build a longitudinal study across the Illawarra Shoalhaven region to determine all of the factors that are drivers of antimicrobial resistance and to provide a platform for test interventions.University of Wollongong, Illawarra Shoalhaven Local Health District
- 5 July 2018WARRA was established as an initiative out of the University of Wollongong, NSW. It aims to generate evidence on antibiotic use and drivers of antimicrobial resistance, to inform future interventions targeting the Illawarra Shoalhaven region. WARRA is comprised of researchers and clinicians specialising in molecular life science, infectious diseases, psychology, nursing, pharmacy, microbiology, pathology and research/project management.University of Wollongong, Illawarra Shoalhaven Local Health District